Interrogating the SARS-CoV-2 specific immune response with single cell resolution: End to end workflow
SARS-CoV-2, responsible for COVID-19 disease, has erupted a unifying collaborative response effort to elucidate and define protective immunity to guide development of therapeutics and vaccines.
You will learn:
- How dCODE™ Dextramer® technology adds a unique DNA barcode to the MHC Dextramer® reagent, allowing detection of antigen-specific T cells
- Why sample preparation for genomic applications using microfluidic-based cell sorting improves the sequencing data of downstream applications
- How combining dCODE Dextramer reagent with the 5’ immune solution from 10X Genomics can help COVID-19 research move forward
This webinar gives you an end to end view of how the workflow between Immudex, Nanocellect, and 10X Genomics empowers antigen specific immune profiling for COVID-19 research.